Mark H. Wilcox
Impact in
- Infectious Diseases top 0.01%
- Clostridium difficile and Clostridium perfringens research
- Viral gastroenteritis research and epidemiology
- Antimicrobial Resistance in Staphylococcus
-
- Nosocomial Infections in ICU
Papers in
-
- Clostridium difficile and Clostridium perfringens research 256
- Antimicrobial Resistance in Staphylococcus 85
- Viral gastroenteritis research and epidemiology 66
- Epidemiology 124
- Microscopic Colitis 95
- Co-authors
- Dale N. Gerding (14 shared papers)Ed J. Kuijper (31 shared papers)Warren N. Fawley (55 shared papers)Stuart Johnson (8 shared papers)Vivian G. Loo (7 shared papers)Ciarán P. Kelly (6 shared papers)Jane Freeman (50 shared papers)Maja Rupnik (10 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (58 papers)Journal of Hospital Infection (42 papers)Clinical Infectious Diseases (25 papers)Journal of Clinical Microbiology (20 papers)Clinical Microbiology and Infection (18 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Mark H. Wilcox
429 papers receiving 27.6k citations
Mark H. Wilcox's Hit Papers
Peers
Comparison fields: 5 of 190
- Infectious Diseases 21.4k
- Critical Care and Intensive Care Medicine 2.6k
- Applied Microbiology and Biotechnology 790
- Epidemiology 9.5k
- Gastroenterology 1.4k
Countries citing papers authored by Mark H. Wilcox
This map shows the geographic impact of Mark H. Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Wilcox more than expected).
Fields of papers citing papers by Mark H. Wilcox
This network shows the impact of papers produced by Mark H. Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Wilcox. The network helps show where Mark H. Wilcox may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark H. Wilcox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 439 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Hit paper breakdown → | 2010 | 2298 |
| 2 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) Hit paper breakdown → | 2017 | 1927 |
| 3 | Clostridium difficile infection: new developments in epidemiology and pathogenesis Hit paper breakdown → | 2009 | 1134 |
| 4 | epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England Hit paper breakdown → | 2013 | 876 |
| 5 | Clostridium difficile infection in Europe: a hospital-based survey Hit paper breakdown → | 2010 | 835 |
| 6 | Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) Hit paper breakdown → | 2018 | 799 |
| 7 | The Changing Epidemiology of Clostridium difficile Infections Hit paper breakdown → | 2010 | 642 |
| 8 | Clostridium difficile infection Hit paper breakdown → | 2016 | 622 |
| 9 | Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing Hit paper breakdown → | 2013 | 492 |
| 10 | epic2: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England Hit paper breakdown → | 2007 | 485 |
| 11 | European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection Hit paper breakdown → | 2016 | 408 |
| 12 | Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults Hit paper breakdown → | 2021 | 406 |
| 13 | 2009 | 387 | |
| 14 | European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults Hit paper breakdown → | 2021 | 373 |
| 15 | 2013 | 322 | |
| 16 | 2009 | 310 | |
| 17 | 2008 | 304 | |
| 18 | 2020 | 264 | |
| 19 | 2009 | 258 | |
| 20 | 2001 | 237 |
About Mark H. Wilcox
Mark H. Wilcox is a scholar working on Infectious Diseases, Epidemiology, Critical Care and Intensive Care Medicine, Molecular Biology and Clinical Biochemistry, having authored 439 papers that have together received 28.3k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (256 papers), Microscopic Colitis (95 papers), Antimicrobial Resistance in Staphylococcus (85 papers), Viral gastroenteritis research and epidemiology (66 papers), Nosocomial Infections in ICU (49 papers), Bacterial Identification and Susceptibility Testing (39 papers), Gut microbiota and health (29 papers) and Antibiotic Resistance in Bacteria (24 papers). The work is most often cited by research in Infectious Diseases (21.4k citations), Critical Care and Intensive Care Medicine (2.6k citations), Applied Microbiology and Biotechnology (790 citations), Epidemiology (9.5k citations) and Gastroenterology (1.4k citations). Mark H. Wilcox has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Dale N. Gerding, Ed J. Kuijper, Warren N. Fawley, Stuart Johnson, Vivian G. Loo, Ciarán P. Kelly, Jane Freeman, Maja Rupnik, L. Clifford McDonald and Simon D. Baines. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Hospital Infection, Clinical Infectious Diseases, Journal of Clinical Microbiology and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.